Three biomedical engineering faculty receive
NIBIB Trailblazer Awards
Justin Pritchard, assistant professor of biomedical engineering, award title: "Model Driven Construction of Dual-switch Selection Gene Drives to Combat Drug Resistance"
"Our award focuses on a technology that we are calling 'dual switch selection drives.' The goal is to fight drug resistance by using existing drugs, and a novel synthetic control module to sculpt a tumor into a genetic composition that is more curable."
Meghan Vidt, assistant professor of biomedical engineering, award title: "Histotripsy for Collagenous Tissues: a Novel Therapeutic Approach to Tendon Injury"
"This project will develop an ultrasound therapy to treat tendon injury and verify this method using mechanical testing and a computer model. Outcomes of this work will lead to development of a new clinical treatment for patients with a tendon injury."
Lance Lian, assistant professor of biomedical engineering, award title: "Stem cell Immunoengineering for Universal Cardiac Therapy Via CRISPR-Cas9"
"My award focuses on engineering universal stem cell lines, which could be used for cell-based therapies for treating cardiovascular diseases. We will remove some immune related genes from stem cells and also add some other engineered genes into the cells."
|